Linked Data API

Filter

These are the filters currently being used to limit the search results. Click on the remove filter icon to remove the filter.

answering dept short name	Health
legislature › pref label	House of Lords
answer › date of answer	2015-10-22
answer › grouped question UIN	HL2652
max answer › question first answered	2017-12-22T12:35:50.11Z

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are shown at the top of the list. Click on remove this sort to remove a sort and or to reverse the current sort order. Click on the remove all sorting icon to remove all the sorting. Note that sorting can significantly slow down the loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined views, but starred properties are always present no matter what the view. You can star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

Items per page

Choose how many items to view on each page. The more items you view, the longer the page will take to load.

Show Search Form

Search Results

registered interest

date

exactly:

or between:
and

answering body

answering dept id

answering dept short name

answering dept sort name

hansard heading

house id

legislature


pref label

question text

tabling member printed

uin

answer

is ministerial correction

date of answer

exactly:

or between:
and

answer text

answering member printed

grouped question UIN

question first answered

answering member


label

tabling member


label

421282

registered interest

date

14/10/2015

answering body

Department of Health

answering dept id

answering dept short name

Health

answering dept sort name

Health

hansard heading

Amyloidosis

house id

legislature

25277

pref label	House of Lords

question text

To ask Her Majesty’s Government, following the successful Phase 1 trials combining CPHPC and the antibody –SAP for the treatment of Amyloidosis, when they expect Phase 2 trials to commence, and what resource the National Institute for Health Research is making available to University College London to support this work.

tabling member printed

Lord Willis of Knaresborough

uin

HL2653

answer

is ministerial correction

date of answer

22/10/2015

answer text

Results in the first 15 patients with systemic amyloidosis treated with a combination of CPHPC and anti-SAP antibody have been published in the New England Journal of Medicine. The phase I study is funded by GlaxoSmithKline (GSK) and the research team includes researchers at University College London (UCL) and the National Amyloidosis Centre (NAC). The National Institute for Health Research Clinical Research Network (CRN) provides support to help the life sciences industry delivery high quality commercial contract clinical research in the national health service. If a phase II trial is developed, the CRN will work with GSK, the NAC and UCL as appropriate, to deliver the trial.

answering member printed

Lord Prior of Brampton

grouped question UIN

HL2652

question first answered

22/10/2015 12:13:17

answering member

127

label	Biography information for Lord Prior of Brampton

tabling member

4151

label	Biography information for Lord Willis of Knaresborough